Kintara Therapeutics PEG Ratio

Kintara Therapeutics (KTRA) currently reports a PEG ratio of 127.96. That is above the Materials sector average of 16.09. Use the charts on this page to explore Kintara Therapeutics's PEG ratio history and peer comparisons.

Kintara Therapeutics's PEG ratio of 127.96 is higher than the Materials sector average of 16.09. That is roughly 695.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Kintara Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At 127.96, KTRA can look expensive or cheap only in context — versus its own history, growth rate, and Materials peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 127.96, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 16.09. From there, open related valuation or income-statement pages for Kintara Therapeutics, and consider following KTRA for alerts when major investors trade the stock.

Kintara Therapeutics is classified in the Materials sector. On PEG ratio, it currently shows 127.96 versus a sector average near 16.09. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing KTRA with unrelated industries.